Ten63 Therapeutics

Durham, United States

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.

Dec 2024

Series A

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Draper AssociatesSOSVHatteras Venture PartnersIndieBioAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ten63 Therapeutics

Who are Ten63 Therapeutics's investors?

Ten63 Therapeutics's investors include Draper Associates, SOSV, Hatteras Venture Partners, IndieBio, Alexandria Venture Investments.

Where is Ten63 Therapeutics headquartered?

Ten63 Therapeutics is headquartered in Durham, United States.

What does Ten63 Therapeutics do?

Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.

What stage is Ten63 Therapeutics at?

Ten63 Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 19, 2024.

MLA

"Ten63 Therapeutics — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/ten63-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2024). Ten63 Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ten63-therapeutics

Wikipedia (cite web)

{{cite web |title=Ten63 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ten63-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 19, 2024.

Similar Companies in Biotechnology